Verrica Pharmaceuticals Inc. (VRCA) Financials

VRCA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 36.0 million 31.7 million
March 31, 2026 38.8 million 22.7 million
Dec. 31, 2025 47.1 million 22.4 million
Sept. 30, 2025 40.9 million 57.9 million

VRCA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -9.3 million 1.2 million
March 31, 2026 -9.2 million 897000
Dec. 31, 2025 -4.6 million 686000
Sept. 30, 2025 9.7 million 718000

VRCA Net Income

No data available :(

VRCA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 11.2 million - 1.8 million
March 31, 2026 20.6 million - 698000
Dec. 31, 2025 30.1 million - 1.6 million
Sept. 30, 2025 21.1 million 21.6 million 1.7 million

VRCA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 21.3 million
March 31, 2026 21.3 million
Dec. 31, 2025 10.7 million
Sept. 30, 2025 9.5 million

VRCA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 6.0 million 10.3 million 6.5 million
March 31, 2026 - 3.9 million 10.0 million -
Dec. 31, 2025 - 2.5 million 8.1 million 300000
Sept. 30, 2025 - 2.2 million 9.4 million -

VRCA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 5.9 million 878000
March 31, 2026 5.0 million 889000
Dec. 31, 2025 5.1 million 1.4 million
Sept. 30, 2025 14.3 million 1.1 million

VRCA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VRCA

Price: $4.68

52 week price:
3.28
9.82

Earnings Per Share: -1.69 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 337100

Market Capitalization: 87.4 million

Links: